James Garner, Chief Executive Officer at Kazia Therapeutics Ltd, holds 781.82K shares in Kazia Therapeutics Ltd (Ticker: DE:NV9). Most recently, James Garner Bought €181,819 shares of Kazia Therapeutics Ltd on Mar 06, 2023 for an estimated value of 20.00K.